Literature DB >> 8978365

A new syndrome of Crohn's disease and pachydermoperiostosis in a family.

R F Compton1, W J Sandborn, H Yang, N M Lindor, W J Tremaine, M D Davis, A A Khalil, N A Tountas, D B Tyan, C J Landers, K D Taylor, T R Viggiano, E L Matteson, A L Schroeter, S E Plevy, F Cominelli, S R Targan, J I Rotter.   

Abstract

Few syndromic associations with Crohn's disease are described. The aim of this study was to characterize a new syndrome of Crohn's disease associated with pachydermoperiostosis in 3 brothers. Three probands, 6 siblings, both parents, 20 of 21 third-generation relatives, and 9 spousal controls were evaluated. Serological evaluation for antineutrophil cytoplasmic antibodies and human leukocyte antigens as well as genetic testing for tumor necrosis factor microsatellites, intercellular adhesion molecule 1 polymorphisms, the interleukin 1 receptor antagonist gene, and the interleukin 1 beta gene were performed. Only the 3 probands were affected and developed pachydermoperiostosis between ages 14 and 17 years. Pachydermoperiostosis preceded Crohn's ileocolitis by 6 and 20 years in two probands, excluding secondary hypertrophic osteoarthropathy. Two probands were antineutrophil cytoplasmic antibody positive vs. 1 of 27 unaffected relatives (P < 0.001, chi 2). Haplotypes for human leukocyte antigen and tumor necrosis factor microsatellites were discordant. The probands' generation was homozygous for the common allele 1 of the interleukin 1 receptor antagonist and interleukin 1 beta genes. Two probands carried a rare polymorphism of the intercellular adhesion molecule 1 gene. A new syndrome of Crohn's disease and pachydermoperiostosis associated with antineutrophil cytoplasmic antibodies is described. Inheritance is most likely autosomal recessive by pedigree. No clear association was found between this syndrome and the gene regions evaluated.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8978365     DOI: 10.1016/s0016-5085(97)70241-5

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  6 in total

1.  Identification of a novel mycobacterial histone H1 homologue (HupB) as an antigenic target of pANCA monoclonal antibody and serum immunoglobulin A from patients with Crohn's disease.

Authors:  O Cohavy; G Harth; M Horwitz; M Eggena; C Landers; C Sutton; S R Targan; J Braun
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

2.  Pachydermoperiostosis-critical analysis with report of five unusual cases.

Authors:  Anna Latos-Bielenska; Ivo Marik; Miroslaw Kuklik; Anna Materna-Kiryluk; Czeslaw Povysil; Kazimierz Kozlowski
Journal:  Eur J Pediatr       Date:  2007-02-07       Impact factor: 3.183

Review 3.  The history of genetics in inflammatory bowel disease.

Authors:  Weronica E Ek; Mauro D'Amato; Jonas Halfvarson
Journal:  Ann Gastroenterol       Date:  2014

4.  Immunohistochemical differentiation between chronic enteropathy associated with SLCO2A1 gene and other inflammatory bowel diseases.

Authors:  Satoko Yamaguchi; Shunichi Yanai; Shotaro Nakamura; Keisuke Kawasaki; Makoto Eizuka; Noriyuki Uesugi; Tamotsu Sugai; Junji Umeno; Motohiro Esaki; Takayuki Matsumoto
Journal:  Intest Res       Date:  2018-07-27

5.  Clinical features of chronic enteropathy associated with SLCO2A1 gene: a new entity clinically distinct from Crohn's disease.

Authors:  Junji Umeno; Motohiro Esaki; Atsushi Hirano; Yuta Fuyuno; Naoki Ohmiya; Shigeyoshi Yasukawa; Fumihito Hirai; Shuji Kochi; Koichi Kurahara; Shunichi Yanai; Keiichi Uchida; Shuhei Hosomi; Kenji Watanabe; Naoki Hosoe; Haruhiko Ogata; Tadakazu Hisamatsu; Manabu Nagayama; Hironori Yamamoto; Daiki Abukawa; Fumihiko Kakuta; Kei Onodera; Toshiyuki Matsui; Toshifumi Hibi; Tsuneyoshi Yao; Takanari Kitazono; Takayuki Matsumoto
Journal:  J Gastroenterol       Date:  2018-01-08       Impact factor: 7.527

6.  Characteristic Facial Appearance Was the Key to Diagnosing Chronic Enteropathy Associated with <i>SLCO2A1</i>-associated Primary Hypertrophic Osteoarthropathy.

Authors:  Akira Sonoda; Yasuhiro Wada; Kazumi Togo; Kazuhiro Mizukami; Yuta Fuyuno; Junji Umeno; Shin Fujioka; Kensuke Fukuda; Kazuhisa Okamoto; Ryo Ogawa; Tadayoshi Okimoto; Kazunari Murakami
Journal:  Intern Med       Date:  2019-10-15       Impact factor: 1.271

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.